APONVI Trademark

Trademark Overview


On Tuesday, September 21, 2021, a trademark application was filed for APONVI with the United States Patent and Trademark Office. The USPTO has given the APONVI trademark a serial number of 97038307. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Heron Therapeutics, Inc.. The APONVI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
aponvi

General Information


Serial Number97038307
Word MarkAPONVI
Filing DateTuesday, September 21, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesAnti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameHeron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, September 24, 2021NEW APPLICATION ENTERED
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Thursday, June 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 11, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, December 4, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 21, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2023SOU EXTENSION 1 FILED
Wednesday, June 21, 2023SOU EXTENSION 1 GRANTED
Friday, June 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 2 FILED
Wednesday, December 13, 2023SOU EXTENSION 2 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED